why is semaglutide being banned Critics debate banning GLP-1 weight-loss medications in sports for their potential as performance enhancers. link in bio ๐ Belgium plans temporary ban on
Description
Hernandez NS et al
It acts on GLP-1 receptors in the pancreas, hypothalamus, and gastrointestinal tract to modulate insulin secretion, satiety, and gastric emptying
A study published in the journal Obesity examined alternative dosing regimens for GLP-1 receptor agonists and found that altering dosing frequency does not proportionally reduce efficacy
doi: 10.1016/S0140-6736(18)31773-2 59 AhrnBMasmiquelLKumarHSarginMKarsblJDJacobsenSHet al
Reassurance is not included
